Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
4BIO Capital is a London-based venture capital firm specializing in the advanced therapies sector. The firm focuses on early-stage investments in biotech and healthcare, particularly in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The team comprises experts from medicine, finance, and academia, including several PhDs and industry veterans.
4BIO Capital invests in early-stage companies within the advanced therapies sector, targeting areas such as cell therapy, gene therapy, RNA-based therapy, targeted therapies, and microbiome-related treatments. Their investment strategy is designed to address significant medical and social needs, particularly those with high unmet medical requirements.
Email info@4biocapital.com with your deck to pitch 4BIO Capital.
Yes, 4BIO Capital often leads investment rounds in the companies they support, particularly in the early stages.
The firm is open to follow-on investments, especially if the company continues to align with their focus on advanced therapies and demonstrates growth potential.
Specific fund size details are not publicly available, but the firm focuses on pre-seed, seed, and seed-plus stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.